Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ACOR Acorda Therapeutics

Watchlist
0.297
+0.021+7.45%
Trading Session 09/30 11:56 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
0.300
Open
0.280
Turnover
16.34K
Low
0.280
Pre Close
0.277
Volume
57.08K
Market Cap
7.24M
P/E(TTM)
Loss
52wk High
4.900
Shares
24.34M
P/E(Static)
Loss
52wk Low
0.261
Float Cap
6.37M
Bid/Ask %
-75.00%
Historical High
272.700
Shs Float
21.43M
Volume Ratio
0.85
Historical Low
0.261
Dividend TTM
--
Div Yield TTM
--
P/B
0.08
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.27%
Amplitude
7.26%
Avg Price
0.286
Lot Size
1
Float Cap
6.37M
Bid/Ask %
-75.00%
Historical High
272.700
Shs Float
21.43M
Volume Ratio
0.85
Historical Low
0.261
Dividend TTM
--
P/B
0.08
Dividend LFY
--
Turnover Ratio
0.27%
Amplitude
7.26%
Avg Price
0.286
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson’s disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
CEO: Cohen M.D., Ron
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top